Chronic Wound Care Market Size, Share & Trends Analysis Report By Product (Advanced Wound Dressing, Surgical Wound Care, Traditional Wound Care, Wound Therapy Devices), By Application (Diabetic Foot Ulcers, Pressure Ulcers), By End Use, By Region, And Seg
Description
Chronic Wound Care Market Summary
The global chronic wound care market size was estimated at USD 13.8 billion in 2024 and is projected to reach USD 19.5 billion by 2033, growing at a CAGR of 4.11% from 2025 to 2033. The chronic wound care market continues to expand due to rising diabetes-related ulcers, a growing geriatric population, and increasing prevalence of pressure and venous leg ulcers.
Adoption of advanced dressings, NPWT systems, and infection-control technologies-combined with greater investment in specialty wound centers and home-care services-is further accelerating market growth. According to the article published by the National Rural Health Association in November 2025, diabetic foot ulcers (DFU) significantly strain Critical Access Hospitals (CAH). With 38.4 million Americans living with diabetes and higher prevalence in rural regions, DFUs drive more hospitalizations, emergency visits, and wound-care needs. This increases clinical workload, resource pressure, and operating costs for CAHs. The article emphasizes that structured wound-care programs and regular podiatry screenings can reduce complications and improve patient retention
The chronic wound care market is driven by the growing number of patients living with long-lasting ulcers and the associated treatment costs. The rising clinical and economic burden of chronic wounds continues to be a significant driver for growth in the chronic wound care market. According to an article published in the journal Advances in Wound Care in 2025, chronic wounds affect an estimated 10.5 million Medicare beneficiaries in the U.S., creating substantial demand for ongoing treatment. The journal reports that Medicare spends tens of billions of dollars annually due to slow-healing ulcers, complications, and recurrent hospitalizations. As populations age and diabetes, obesity, and vascular disease increase, payers and providers are forced to invest more in advanced wound care solutions, sustaining long-term market growth.
Global Chronic Wound Care Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global chronic wound care market report based on product, application, end use, and region:
The global chronic wound care market size was estimated at USD 13.8 billion in 2024 and is projected to reach USD 19.5 billion by 2033, growing at a CAGR of 4.11% from 2025 to 2033. The chronic wound care market continues to expand due to rising diabetes-related ulcers, a growing geriatric population, and increasing prevalence of pressure and venous leg ulcers.
Adoption of advanced dressings, NPWT systems, and infection-control technologies-combined with greater investment in specialty wound centers and home-care services-is further accelerating market growth. According to the article published by the National Rural Health Association in November 2025, diabetic foot ulcers (DFU) significantly strain Critical Access Hospitals (CAH). With 38.4 million Americans living with diabetes and higher prevalence in rural regions, DFUs drive more hospitalizations, emergency visits, and wound-care needs. This increases clinical workload, resource pressure, and operating costs for CAHs. The article emphasizes that structured wound-care programs and regular podiatry screenings can reduce complications and improve patient retention
The chronic wound care market is driven by the growing number of patients living with long-lasting ulcers and the associated treatment costs. The rising clinical and economic burden of chronic wounds continues to be a significant driver for growth in the chronic wound care market. According to an article published in the journal Advances in Wound Care in 2025, chronic wounds affect an estimated 10.5 million Medicare beneficiaries in the U.S., creating substantial demand for ongoing treatment. The journal reports that Medicare spends tens of billions of dollars annually due to slow-healing ulcers, complications, and recurrent hospitalizations. As populations age and diabetes, obesity, and vascular disease increase, payers and providers are forced to invest more in advanced wound care solutions, sustaining long-term market growth.
Global Chronic Wound Care Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global chronic wound care market report based on product, application, end use, and region:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Advanced Wound Dressing
- Foam Dressing
- Hydrocolloid Dressing
- Film Dressing
- Alginate Dressing
- Hydrogel Dressing
- Collagen Dressing
- Other Dressing
- Surgical Wound Care
- Suture & Staples
- Tissue Adhesive & Sealants
- Anti-infective Dressing
- Traditional Wound Care
- Medical Tapes
- Cleansing Agents
- Others
- Wound Therapy Devices
- Negative Pressure Wound Therapy
- Oxygen and Hyperbaric Oxygen Equipment
- Electric Stimulation Devices
- Pressure Relief Devices
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Other Chronic Wounds
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Home Healthcare
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
110 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. End-use
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- Chapter 3. Chronic Wound Care Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising Prevalence of Diabetes and Obesity
- 3.2.1.2. Growth in the Aging Population
- 3.2.1.3. Increase in Surgical Procedures and Post-operative Wound Incidence
- 3.2.2. Market restraint analysis
- 3.2.2.1. High Cost Of Advanced Wound Care Products And Chronic Wound Treatments
- 3.2.2.2. Delayed Diagnosis And Lower Treatment Rates In Emerging Nations
- 3.2.3. Market opportunity analysis
- 3.2.3.1. Expansion of Home-based Chronic Wound Management
- 3.2.3.2. Rising Demand for Antimicrobial, Bioactive, and Smart Dressings
- 3.2.4. Market challenge analysis
- 3.2.4.1. Risk of Infection, Delayed Healing, and Product-related Failures
- 3.2.4.2. Strong Competition and Pricing Pressure
- 3.3. Chronic Wound Care Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal Landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
- Chapter 4. Chronic Wound Care Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Chronic Wound Care Market Product Movement Analysis
- 4.3. Global Chronic Wound Care Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
- 4.4. Advanced Wound Dressing
- 4.4.1. Advanced Wound Dressing market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.4.2. Foam Dressing
- 4.4.2.1. Foam Dressing market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.4.3. Hydrocolloid Dressing
- 4.4.3.1. Hydrocolloid Dressing market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.4.4. Film Dressing
- 4.4.4.1. Film Dressing market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.4.5. Alginate Dressing
- 4.4.5.1. Alginate Dressing market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.4.6. Hydrogel Dressing
- 4.4.6.1. Hydrogel Dressing market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.4.7. Collagen Dressing
- 4.4.7.1. Collagen Dressing market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.4.8. Other Dressing
- 4.4.8.1. Other Dressing market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.5. Surgical Wound Care
- 4.5.1. Surgical Wound Care market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.5.2. Suture & Staples
- 4.5.2.1. Suture & Staples market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.5.3. Tissue Adhesive & Sealants
- 4.5.3.1. Tissue Adhesive & Sealants market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.5.4. Anti-infective Dressing
- 4.5.4.1. Anti-infective Dressings market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.6. Traditional Wound Care
- 4.6.1. Traditional Wound Care market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.6.2. Medical Tapes
- 4.6.2.1. Medical Tapes market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.6.3. Cleansing Agents
- 4.6.3.1. Cleansing Agents market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.6.4. Others
- 4.6.4.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.7. Wound Therapy Devices
- 4.7.1. Wound Therapy Devices market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.7.2. Negative Pressure Wound Therapy
- 4.7.2.1. Negative Pressure Wound Therapy market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.7.3. Oxygen and Hyperbaric Oxygen Equipment
- 4.7.3.1. Oxygen and Hyperbaric Oxygen Equipment market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.7.4. Electric Stimulation Devices
- 4.7.4.1. Electric Stimulation Devices market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.7.5. Pressure Relief Devices
- 4.7.5.1. Pressure Relief Devices market estimates and forecasts for 2021 to 2033 (USD Million)
- 4.7.6. Others
- 4.7.6.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
- Chapter 5. Chronic Wound Care Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Chronic Wound Care Market Application Movement Analysis
- 5.3. Global Chronic Wound Care Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 5.4. Diabetic Foot Ulcers
- 5.4.1. Diabetic Foot Ulcers market estimates and forecasts for 2021 to 2033 (USD Million)
- 5.5. Pressure Ulcers
- 5.5.1. Pressure Ulcers market estimates and forecasts for 2021 to 2033 (USD Million)
- 5.6. Venous Leg Ulcers
- 5.6.1. Venous Leg Ulcers market estimates and forecasts for 2021 to 2033 (USD Million)
- 5.7. Others
- 5.7.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
- Chapter 6. Umbilical Vessel Catheters: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Chronic Wound Care Market End Use Movement Analysis
- 6.3. Global Chronic Wound Care Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 6.4. Hospitals
- 6.4.1. Hospitals market estimates and forecasts for 2021 to 2033 (USD Million)
- 6.5. Specialty Clinics
- 6.5.1. Specialty clinics market estimates and forecasts for 2021 to 2033 (USD Million)
- 6.6. Home Healthcare
- 6.6.1. Home Healthcare market estimates and forecasts for 2021 to 2033 (USD Million)
- 6.7. Others
- 6.7.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
- Chapter 7. Chronic Wound Care Market: Regional Estimates & Trend Analysis
- 7.1. Regional Dashboard
- 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
- 7.3. North America
- 7.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Competitive scenario
- 7.3.2.3. Regulatory framework
- 7.3.2.4. Reimbursement scenario
- 7.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
- 7.3.3. Canada
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Competitive scenario
- 7.3.3.3. Regulatory framework
- 7.3.3.4. Reimbursement scenario
- 7.3.3.5. Canada market estimates and forecasts, 2021 - 2033
- 7.3.4. Mexico
- 7.3.4.1. Key country dynamics
- 7.3.4.2. Competitive scenario
- 7.3.4.3. Regulatory framework
- 7.3.4.4. Reimbursement scenario
- 7.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
- 7.4. Europe
- 7.4.1. UK
- 7.4.1.1. Key country dynamics
- 7.4.1.2. Competitive scenario
- 7.4.1.3. Regulatory framework
- 7.4.1.4. Reimbursement scenario
- 7.4.1.5. UK market estimates and forecasts, 2021 - 2033
- 7.4.2. Germany
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Competitive scenario
- 7.4.2.3. Regulatory framework
- 7.4.2.4. Reimbursement scenario
- 7.4.2.5. Germany market estimates and forecasts, 2021 - 2033
- 7.4.3. France
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Competitive scenario
- 7.4.3.3. Regulatory framework
- 7.4.3.4. Reimbursement scenario
- 7.4.3.5. France market estimates and forecasts, 2021 - 2033
- 7.4.4. Italy
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Competitive scenario
- 7.4.4.3. Regulatory framework
- 7.4.4.4. Reimbursement scenario
- 7.4.4.5. Italy market estimates and forecasts, 2021 - 2033
- 7.4.5. Spain
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Competitive scenario
- 7.4.5.3. Regulatory framework
- 7.4.5.4. Reimbursement scenario
- 7.4.5.5. Spain market estimates and forecasts, 2021 - 2033
- 7.4.6. Denmark
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Competitive scenario
- 7.4.6.3. Regulatory framework
- 7.4.6.4. Reimbursement scenario
- 7.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
- 7.4.7. Sweden
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Competitive scenario
- 7.4.7.3. Regulatory framework
- 7.4.7.4. Reimbursement scenario
- 7.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
- 7.4.8. Norway
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Competitive scenario
- 7.4.8.3. Regulatory framework
- 7.4.8.4. Reimbursement scenario
- 7.4.8.5. Norway market estimates and forecasts, 2021 - 2033
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Competitive scenario
- 7.5.1.3. Regulatory framework
- 7.5.1.4. Reimbursement scenario
- 7.5.1.5. Japan market estimates and forecasts, 2021 - 2033
- 7.5.2. India
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Competitive scenario
- 7.5.2.3. Regulatory framework
- 7.5.2.4. Reimbursement scenario
- 7.5.2.5. India market estimates and forecasts, 2021 - 2033
- 7.5.3. China
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Competitive scenario
- 7.5.3.3. Regulatory framework
- 7.5.3.4. Reimbursement scenario
- 7.5.3.5. China market estimates and forecasts, 2021 - 2033
- 7.5.4. South Korea
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Competitive scenario
- 7.5.4.3. Regulatory framework
- 7.5.4.4. Reimbursement scenario
- 7.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
- 7.5.5. Australia
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Competitive scenario
- 7.5.5.3. Regulatory framework
- 7.5.5.4. Reimbursement scenario
- 7.5.5.5. Australia market estimates and forecasts, 2021 - 2033
- 7.5.6. Thailand
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Competitive scenario
- 7.5.6.3. Regulatory framework
- 7.5.6.4. Reimbursement scenario
- 7.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
- 7.6. Latin America
- 7.6.1. Brazil
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Competitive scenario
- 7.6.1.3. Regulatory framework
- 7.6.1.4. Reimbursement scenario
- 7.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
- 7.6.2. Argentina
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Competitive scenario
- 7.6.2.3. Regulatory framework
- 7.6.2.4. Reimbursement scenario
- 7.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
- 7.7. MEA
- 7.7.1. South Africa
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Competitive scenario
- 7.7.1.3. Regulatory framework
- 7.7.1.4. Reimbursement scenario
- 7.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
- 7.7.2. Saudi Arabia
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Competitive scenario
- 7.7.2.3. Regulatory framework
- 7.7.2.4. Reimbursement scenario
- 7.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
- 7.7.3. UAE
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Competitive scenario
- 7.7.3.3. Regulatory framework
- 7.7.3.4. Reimbursement scenario
- 7.7.3.5. UAE market estimates and forecasts, 2021 - 2033
- 7.7.4. Kuwait
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Competitive scenario
- 7.7.4.3. Regulatory framework
- 7.7.4.4. Reimbursement scenario
- 7.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.2.1. Innovators
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Global Key company market share analysis, 2024
- 8.3.4. JOHNSON & JOHNSON
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. BAXTER INTERNATIONAL
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Coloplast Corp.
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. 3M
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Medline Industries, Inc.
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. ConvaTec Group PLC
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Derma Sciences (Integra LifeSciences)
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. Cardinal Health
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Mölnlycke Health Care AB
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Product benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.13. Paul Hartmann AG
- 8.3.13.1. Company overview
- 8.3.13.2. Financial performance
- 8.3.13.3. Product benchmarking
- 8.3.13.4. Strategic initiatives
- 8.3.14. Smith & Nephew PLC
- 8.3.14.1. Company overview
- 8.3.14.2. Financial performance
- 8.3.14.3. Product benchmarking
- 8.3.14.4. Strategic initiatives
- 8.4. Heat Map Analysis/ Company Market Position Analysis
- 8.5. Estimated Company Market Share Analysis, 2024
- 8.6. List of Other Key Market Players
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
